Cytomed Therapeutics Limited (GDTC)

$0.78 +0.06 (7.85%)
Market Cap 8.56M
Revenue (ttm) 250,000.00
Net Income (ttm) -3.10M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,240.00%
Debt to Equity Ratio 0.06
Volume 119,800
Avg Vol 12,138
Day's Range N/A - N/A
Shares Out 11.83M
Stochastic %K 31%
Beta -0.18
Analysts Strong Buy
Price Target $5.00

Company Profile

CytoMed Therapeutics Limited, a pre-clinical biopharmaceutical company, focuses on developing novel cell-based immunotherapies for the treatment of human cancers and degenerative diseases in Malaysia and Singapore. The company's lead product candidate is CTM-N2D, an expanded gamma delta T cells grafted with natural killer group 2D ligands-targeting chimeric antigen receptor, which is in Phase I clinical trials comprising to improve anti-cancer cytotoxicity. It is also developing iPSC-gdNKT, a pl...

Industry: Biotechnology
Sector: Healthcare
Phone: 65 6250 7738
Address:
1 Commonwealth Lane, No. 08-22, Singapore, Singapore
SuperGreenToday
SuperGreenToday May. 1 at 11:18 PM
$GDTC
1 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Apr. 27 at 11:19 PM
$GDTC RSI: 42.98, MACD: -0.0139 Vol: 0.02, MA20: 1.00, MA50: 1.03 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 23 at 2:17 AM
$GDTC RSI: 66.67, MACD: -0.0402 Vol: 0.11, MA20: 0.96, MA50: 1.21 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
ValuationExpert
ValuationExpert Feb. 18 at 4:37 PM
$GDTC Cyngn develops autonomous vehicle software for industrial use. Adoption timelines remain uncertain. Funding risk persists.
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 17 at 3:55 PM
$GDTC Current Stock Price: $0.99
0 · Reply
vnukr
vnukr Feb. 8 at 4:54 PM
$GDTC Bears are strongly holding price between 1 $ to 1.19$. Breaking 1.30$ is the key enter…
1 · Reply
vnukr
vnukr Feb. 6 at 8:58 PM
$GDTC what’s going?
1 · Reply
vnukr
vnukr Feb. 6 at 3:19 PM
$GDTC $LIMN Both are having starting problem. Once they get volume, no one stop them…
0 · Reply
vnukr
vnukr Feb. 6 at 3:15 PM
$GDTC Bears are testing Real bulls
0 · Reply
vnukr
vnukr Feb. 6 at 3:12 PM
$GDTC Shorts are pulling shares below VWAP and adding nicely with 5% profit…retailers are losing mony due to stop loss..
0 · Reply
Latest News on GDTC
Cytomed Therapeutics refutes ‘misleading’ claims, reaffirms clinical progress

2026-01-28T15:11:19.000Z - 3 months ago

Cytomed Therapeutics refutes ‘misleading’ claims, reaffirms clinical progress

Cytomed sees ‘enough resources’ to continue activites for ‘at least a year’

2026-01-13T13:17:24.000Z - 4 months ago

Cytomed sees ‘enough resources’ to continue activites for ‘at least a year’

Cytomed Therapeutics enters into MoU with UMMC

2025-12-08T13:16:15.000Z - 5 months ago

Cytomed Therapeutics enters into MoU with UMMC

CytoMed completes acquisition of T cell technology of TC BioPharm

2025-11-18T14:37:12.000Z - 6 months ago

CytoMed completes acquisition of T cell technology of TC BioPharm

Cytomed Therapeutics secures investment for subsidiary LongevityBank

2025-11-06T13:42:55.000Z - 6 months ago

Cytomed Therapeutics secures investment for subsidiary LongevityBank

Cytomed Therapeutics chairman Peter Choo increases holdings to 21.95%

2025-10-22T12:21:29.000Z - 7 months ago

Cytomed Therapeutics chairman Peter Choo increases holdings to 21.95%

Cytomed announces cash bid for potential acquisition of TC BioPharm

2025-10-14T12:05:18.000Z - 7 months ago

Cytomed announces cash bid for potential acquisition of TC BioPharm

CytoMed Therapeutics Earnings Call Transcript: H1 2025

Oct 2, 2025, 10:00 AM EDT - 7 months ago

CytoMed Therapeutics Earnings Call Transcript: H1 2025

Cytomed Therapeutics announces publication of research on T cells

2025-10-02T11:05:40.000Z - 7 months ago

Cytomed Therapeutics announces publication of research on T cells

CytoMed Therapeutics Announces Publication of Collaborative Research with The University of Texas, MD Anderson Cancer Center, Demonstrating the Potential of Allogeneic γδ T Cells in Acute Myeloid Leukemia

Oct 2, 2025, 7:00 AM EDT - 7 months ago

CytoMed Therapeutics Announces Publication of Collaborative Research with The University of Texas, MD Anderson Cancer Center, Demonstrating the Potential of Allogeneic γδ T Cells in Acute Myeloid Leukemia

Cytomed Therapeutics expanded into auto-immune diseases

2025-08-28T13:11:41.000Z - 9 months ago

Cytomed Therapeutics expanded into auto-immune diseases

Update on recent acquisition - CytoMed Therapeutics expands into auto-immune diseases building on its recent cord blood bank acquisition

Aug 28, 2025, 9:00 AM EDT - 9 months ago

Update on recent acquisition - CytoMed Therapeutics expands into auto-immune diseases building on its recent cord blood bank acquisition

Cytomed Therapeutics announces $4.3M at-the-market offering program

2025-08-19T02:55:05.000Z - 9 months ago

Cytomed Therapeutics announces $4.3M at-the-market offering program

CytoMed Therapeutics Limited Announces At-the-Market (ATM) Offering Program

Aug 18, 2025, 9:00 PM EDT - 9 months ago

CytoMed Therapeutics Limited Announces At-the-Market (ATM) Offering Program

Cytomed Therapeutics completes dose level 1 of ANGELICA trial

2025-07-21T14:05:22.000Z - 10 months ago

Cytomed Therapeutics completes dose level 1 of ANGELICA trial

Update On Clinical Trial Milestone - CytoMed Therapeutics Achieves Completion of Dose Level 1 of its ANGELICA TRIAL, and Proceeding to Dose Level 2 in Patients with Advanced Solid Tumors or Haematological Malignancies

Jul 21, 2025, 10:01 AM EDT - 10 months ago

Update On Clinical Trial Milestone - CytoMed Therapeutics Achieves Completion of Dose Level 1 of its ANGELICA TRIAL, and Proceeding to Dose Level 2 in Patients with Advanced Solid Tumors or Haematological Malignancies

Cytomed Therapeutics files $50M mixed securities shelf

2025-06-13T20:20:11.000Z - 11 months ago

Cytomed Therapeutics files $50M mixed securities shelf

CytoMed Therapeutics Reports Full Year Ended December 31, 2024 Financial Results and Provides Clinical and Corporate Updates

Apr 28, 2025, 4:05 PM EDT - 1 year ago

CytoMed Therapeutics Reports Full Year Ended December 31, 2024 Financial Results and Provides Clinical and Corporate Updates

Cytomed Therapeutics anticipates readout of ANGELICA trial mid-year

2025-02-06T12:25:35.000Z - 1 year ago

Cytomed Therapeutics anticipates readout of ANGELICA trial mid-year

CytoMed Therapeutics announces Chairman's Letter to the Company's shareholders

Feb 6, 2025, 7:20 AM EST - 1 year ago

CytoMed Therapeutics announces Chairman's Letter to the Company's shareholders

Cytomed Therapeutics entered into BRCA with SunAct

2025-01-06T12:10:32.000Z - 1 year ago

Cytomed Therapeutics entered into BRCA with SunAct

Cytomed Therapeutics announces first patient dosed in ANGELICA Trial

2024-11-20T12:26:12.000Z - 1 year ago

Cytomed Therapeutics announces first patient dosed in ANGELICA Trial

CytoMed Therapeutics Earnings Call Transcript: H1 2024

Oct 8, 2024, 9:00 AM EDT - 1 year ago

CytoMed Therapeutics Earnings Call Transcript: H1 2024

Cytomed Therapeutics announces NMRC co-funding support for ANGELICA trial

2024-10-07T11:51:37.000Z - 1 year ago

Cytomed Therapeutics announces NMRC co-funding support for ANGELICA trial

Cytomed Therapeutics acquires assets and license of Malaysian cord blood bank

2024-10-05T07:51:09.000Z - 1 year ago

Cytomed Therapeutics acquires assets and license of Malaysian cord blood bank

Cytomed Therapeutics 1H EPS (S$0.09) vs. (S$0.22) last year

2024-09-30T11:33:03.000Z - 1 year ago

Cytomed Therapeutics 1H EPS (S$0.09) vs. (S$0.22) last year

Presenting on the Emerging Growth Conference 74 Day 1 on August 21 Register Now

Aug 20, 2024, 7:00 AM EDT - 1 year ago

Presenting on the Emerging Growth Conference 74 Day 1 on August 21 Register Now

CIA CVKD ELUT EUDA GOSS GOVX IMRN

Cytomed Therapeutics acquires cord blood bank license, assets

2024-07-17T11:02:09.000Z - 1 year ago

Cytomed Therapeutics acquires cord blood bank license, assets

CytoMed Therapeutics Acquires Cord Blood Banking Licence and Assets to Entrench Its Strategy in Allogeneic, Off-the-shelf Donor-derived Gamma Delta (γδ) T Cells Technology for Solid and Liquid Cancers

Jul 17, 2024, 7:00 AM EDT - 1 year ago

CytoMed Therapeutics Acquires Cord Blood Banking Licence and Assets to Entrench Its Strategy in Allogeneic, Off-the-shelf Donor-derived Gamma Delta (γδ) T Cells Technology for Solid and Liquid Cancers

CytoMed Diversifies into Regenerative Medicine after Research Collaboration with Singapore's Sengkang General Hospital to Test Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Regeneration

Mar 20, 2024, 8:30 AM EDT - 2 years ago

CytoMed Diversifies into Regenerative Medicine after Research Collaboration with Singapore's Sengkang General Hospital to Test Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Regeneration

CytoMed Therapeutics to Launch Complimentary Cell Banking for Qualified Shareholders for Future Precision Therapies

Mar 18, 2024, 6:00 AM EDT - 2 years ago

CytoMed Therapeutics to Launch Complimentary Cell Banking for Qualified Shareholders for Future Precision Therapies

CytoMed Therapeutics Limited Announces Research Collaboration with Singapore Sengkang General Hospital to Advance Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Diseases and Repair

Mar 4, 2024, 5:00 AM EST - 2 years ago

CytoMed Therapeutics Limited Announces Research Collaboration with Singapore Sengkang General Hospital to Advance Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Diseases and Repair

Malaysian Patent Granted for CytoMed Therapeutics' Licensed Allogeneic CAR-Gamma Delta T Cell Technology

Jan 29, 2024, 7:00 AM EST - 2 years ago

Malaysian Patent Granted for CytoMed Therapeutics' Licensed Allogeneic CAR-Gamma Delta T Cell Technology

CytoMed Therapeutics Signs HOA and MOU to Advance Research on Allogeneic Gamma Delta T Cell Technology

Dec 5, 2023, 7:30 AM EST - 2 years ago

CytoMed Therapeutics Signs HOA and MOU to Advance Research on Allogeneic Gamma Delta T Cell Technology

CytoMed Therapeutics Reports First Half 2023 Financial Report and Provides Corporate Update

Nov 17, 2023, 9:21 AM EST - 2 years ago

CytoMed Therapeutics Reports First Half 2023 Financial Report and Provides Corporate Update

CytoMed Therapeutics to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference

Nov 14, 2023, 7:47 AM EST - 2 years ago

CytoMed Therapeutics to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference

CytoMed Therapeutics Adds to its Intellectual Portfolio After Securing Chinese Patent for its Licensed iPSC-Based Technology

Oct 24, 2023, 1:00 PM EDT - 2 years ago

CytoMed Therapeutics Adds to its Intellectual Portfolio After Securing Chinese Patent for its Licensed iPSC-Based Technology

Chinese Patent Granted for CytoMed Therapeutics' Licensed iPSC-Based Technology

Sep 25, 2023, 7:00 AM EDT - 2 years ago

Chinese Patent Granted for CytoMed Therapeutics' Licensed iPSC-Based Technology

CytoMed Expands Research Collaboration into China After Entering Into MOU

Aug 29, 2023, 9:00 AM EDT - 2 years ago

CytoMed Expands Research Collaboration into China After Entering Into MOU

CytoMed Therapeutics Limited to Present at the August 24th Virtual Investor Summit

Aug 17, 2023, 7:30 AM EDT - 2 years ago

CytoMed Therapeutics Limited to Present at the August 24th Virtual Investor Summit

CytoMed Therapeutics Announces China Research Collaboration to Enhance its Allogeneic CAR γD T In Vivo Persistency

Aug 15, 2023, 1:00 PM EDT - 2 years ago

CytoMed Therapeutics Announces China Research Collaboration to Enhance its Allogeneic CAR γD T In Vivo Persistency

Chinese Patent Granted for A*STAR Spinoff, CytoMed Therapeutics' Licensed Allogeneic CAR-Gamma Delta T Cell Technology

Aug 1, 2023, 7:00 AM EDT - 3 years ago

Chinese Patent Granted for A*STAR Spinoff, CytoMed Therapeutics' Licensed Allogeneic CAR-Gamma Delta T Cell Technology

CytoMed Therapeutics Announces U.S. Patent Granted For its Licensed, Novel CAR-Gamma Delta T Cell Technology

Jul 27, 2023, 9:00 AM EDT - 3 years ago

CytoMed Therapeutics Announces U.S. Patent Granted For its Licensed, Novel CAR-Gamma Delta T Cell Technology

A*STAR Spinoff CytoMed Therapeutics Announce a Patent for its Licensed CAR-Gamma Delta T Cell Technology Has Been Granted in the US

Jul 6, 2023, 7:00 AM EDT - 3 years ago

A*STAR Spinoff CytoMed Therapeutics Announce a Patent for its Licensed CAR-Gamma Delta T Cell Technology Has Been Granted in the US

CytoMed Therapeutics to Ring Nasdaq Closing Bell

May 11, 2023, 9:00 AM EDT - 3 years ago

CytoMed Therapeutics to Ring Nasdaq Closing Bell

CytoMed Therapeutics Limited Announces Collaboration with MD Anderson Cancer Center to Advance Allogeneic Off-the-Shelf Gamma Delta T Cells in Oncology

May 9, 2023, 10:07 AM EDT - 3 years ago

CytoMed Therapeutics Limited Announces Collaboration with MD Anderson Cancer Center to Advance Allogeneic Off-the-Shelf Gamma Delta T Cells in Oncology

CytoMed Therapeutics Limited Announces Pricing of Initial Public Offering

Apr 13, 2023, 8:00 PM EDT - 3 years ago

CytoMed Therapeutics Limited Announces Pricing of Initial Public Offering

SuperGreenToday
SuperGreenToday May. 1 at 11:18 PM
$GDTC
1 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Apr. 27 at 11:19 PM
$GDTC RSI: 42.98, MACD: -0.0139 Vol: 0.02, MA20: 1.00, MA50: 1.03 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 23 at 2:17 AM
$GDTC RSI: 66.67, MACD: -0.0402 Vol: 0.11, MA20: 0.96, MA50: 1.21 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
ValuationExpert
ValuationExpert Feb. 18 at 4:37 PM
$GDTC Cyngn develops autonomous vehicle software for industrial use. Adoption timelines remain uncertain. Funding risk persists.
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 17 at 3:55 PM
$GDTC Current Stock Price: $0.99
0 · Reply
vnukr
vnukr Feb. 8 at 4:54 PM
$GDTC Bears are strongly holding price between 1 $ to 1.19$. Breaking 1.30$ is the key enter…
1 · Reply
vnukr
vnukr Feb. 6 at 8:58 PM
$GDTC what’s going?
1 · Reply
vnukr
vnukr Feb. 6 at 3:19 PM
$GDTC $LIMN Both are having starting problem. Once they get volume, no one stop them…
0 · Reply
vnukr
vnukr Feb. 6 at 3:15 PM
$GDTC Bears are testing Real bulls
0 · Reply
vnukr
vnukr Feb. 6 at 3:12 PM
$GDTC Shorts are pulling shares below VWAP and adding nicely with 5% profit…retailers are losing mony due to stop loss..
0 · Reply
AveraveJoeTrader
AveraveJoeTrader Feb. 6 at 2:19 PM
$GDTC Nice break above the 20 Day MA..let’s see if this can test the 50 next
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 6 at 1:15 PM
$GDTC RSI: 59.31, MACD: -0.1400 Vol: 0.17, MA20: 0.99, MA50: 1.36 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
StockScanners
StockScanners Feb. 6 at 5:53 AM
$GDTC keep watch if this holds above 1.03
0 · Reply
Stock_Catcher
Stock_Catcher Feb. 6 at 3:03 AM
Fortune Friday Watchlist Pt. 1 $CCHH $MB $GDTC $BULL $ONDS Bull Bounce Time?
0 · Reply
DayTrade_4Life
DayTrade_4Life Feb. 6 at 1:44 AM
👀Some Stocks to Watch for Friday 6 Feb: WHLR CCHH WOK CETX DXST $GWAV $LIMN $GDTC 🏆Alerts so far this Week in image below. 🔥See Profile and Pinned Post for more info. 💰Live Alerts, Scanner Alerts, Watchlists, Swing Plays, News, Trading Education, Guidance. 👀Join me on X. Link in Profile.
0 · Reply
vnukr
vnukr Feb. 6 at 1:15 AM
$GDTC $LIMN All porums are watching very closely
0 · Reply
vnukr
vnukr Feb. 6 at 12:47 AM
$GDTC Big players will enter any time
0 · Reply
vnukr
vnukr Feb. 6 at 12:46 AM
$GDTC All short shares were completed.. no shares are available for shorting
0 · Reply
vnukr
vnukr Feb. 5 at 11:41 PM
$GDTC Can we expect any positive PR?
0 · Reply
IIStock_LesnarII
IIStock_LesnarII Feb. 5 at 9:53 PM
$TEAD $GDTC $LIMN $GOOG $WXM TEAD — AH Recovery Shorts over extended Google partnership news Float Float Locked (72% Insider)
0 · Reply
Bossbaby14
Bossbaby14 Feb. 5 at 9:12 PM
$WXM $LIMN $GDTC wxm is on the move 👀😅
0 · Reply
IIStock_LesnarII
IIStock_LesnarII Feb. 5 at 9:08 PM
$TEAD $CISS $GDTC $LIMN $TRUG TEAD — AFTER HOURS FUN LET’S PUSH THIS BACK UP TO .75 Super thin on the way up to .71 Fill the gap
0 · Reply